Academe Learn
CBME Curriculum Preview

Page 9 of 9

MI1.{3-9,11} | General Microbiology II: Laboratory Diagnosis, Specimens & Professionalism — PBL Case

CLINICAL SETTING

Priya, a 26-year-old schoolteacher, presents to the outpatient department of a government medical college in Tamil Nadu with a low-grade fever for three weeks, mild weight loss, and fatigue. She is recently married and lives in a joint family. Her husband accompanies her to the hospital. The consulting physician orders blood tests including HIV ELISA, Widal test, and peripheral smear for malaria, as part of a fever work-up. Priya is not told that HIV testing is being included. The blood sample is collected by a junior intern without any pre-test discussion. The form is sent to the microbiology laboratory with the tests listed, including 'HIV ELISA' written in full on the outward-facing label of the request form.

Trigger 1: The Sample Arrives

At the microbiology laboratory, the ward boy who delivers the sample notices the HIV ELISA request on the form. Later that afternoon, while returning to Priya's ward, he mentions to a ward attendant that 'the teacher in bed 7 has been sent for HIV.' By evening, Priya's mother-in-law — who is visiting — overhears a conversation between two ward attendants who are speculating about the result. She confronts Priya's husband. The Widal test result (positive, titre 1:80) and peripheral smear (no malarial parasites) are returned to the ward. The HIV ELISA result is still awaited.

DISCUSSION POINTS

  • What pre-analytical and consent-related failures occurred at the time of blood collection — and what should have happened instead before an HIV ELISA was ordered and drawn?
  • At what points did a confidentiality breach occur in this scenario, and who bears responsibility for each breach?
  • How should the microbiology laboratory handle HIV ELISA requests on outward-facing request forms — what systems would prevent this specific disclosure pathway?
Click to reveal Trigger 2: The Result (discuss previous trigger first!)

Trigger 2: The Result

The HIV ELISA returns reactive (positive). The laboratory medical officer is informed. She calls the ward physician directly and states: 'HIV ELISA for the patient in bed 7 is positive — please advise.' The ward physician, standing at the nursing station, writes in the case notes: 'HIV positive — refer to ART centre.' Priya's husband reads the case notes when the nursing staff briefly leave the notes on the bedside table. He immediately calls his parents and informs them. Within 24 hours, Priya's in-laws demand she leave the marital home. Priya, who has not yet been formally informed of her result, is now in crisis. The laboratory medical officer has not yet met Priya or provided any post-test counselling.

DISCUSSION POINTS

  • The HIV ELISA is a screening test. What further steps are required before a diagnosis of HIV infection can be confirmed and disclosed to the patient — and why?
  • Multiple communication failures occurred after the reactive ELISA result. Map each failure to the relevant professional standard (MI1.8 or MI1.9) and describe what should have happened instead.
  • What are the specific duties of the microbiology laboratory medical officer at this point — and how do they intersect with the duties of the treating physician?
Click to reveal Trigger 3: Aftermath and Systemic Review (discuss previous trigger first!)

Trigger 3: Aftermath and Systemic Review

The laboratory medical officer, following protocol, arranges for Priya to be counselled in a private setting. A Western blot confirmatory test is ordered. The Western blot returns indeterminate. On repeat ELISA (performed 3 weeks later after a new sample), Priya's HIV ELISA is non-reactive. She was never HIV infected — the initial reactive ELISA was a false positive, likely due to recent malaria exposure causing cross-reactive antibodies. By this time, Priya has been separated from her husband and is in severe psychological distress. The Medical Superintendent has convened an inquiry into the laboratory and ward practices.

DISCUSSION POINTS

  • What does Priya's case illustrate about the concept of 'screening test vs confirmatory test' — and what are the specific harm pathways when an unconfirmed screening result is prematurely disclosed?
  • Using the epidemiological concept of positive predictive value (PPV), explain why a reactive HIV ELISA in a low-prevalence population (like Priya — a monogamous schoolteacher with no known risk factors) has a different clinical meaning than the same result in a high-risk population.
  • As members of the inquiry committee, design a systemic protocol improvement for the laboratory and ward that would prevent recurrence: consider pre-test consent, result disclosure pathways, case notes security, and counselling mandates.

Group Task Assignments

Group 1: Laboratory Systems and Pre-analytical Quality

  • Identify all the laboratory-level failures in this case (consent gap, request form design, result communication pathway) and propose corrective standard operating procedures for each.
  • Research and present the WHO and NACO guidelines on HIV testing consent and pre/post-test counselling in India — what are the legal and ethical obligations?

Competencies: MI1.4, MI1.5, MI1.7

Group 2: Confidentiality, Communication and Patient Rights

  • Map every confidentiality breach in the case chronologically and identify who was responsible at each step. Propose a communication protocol for high-sensitivity laboratory results.
  • Prepare a role-play of the ideal post-test counselling session the laboratory medical officer should have conducted with Priya after receiving the reactive ELISA — before confirming the result and before any disclosure to the family.

Competencies: MI1.8, MI1.9

Group 3: Epidemiology, PPV and Test Interpretation

  • Using Bayes' theorem / PPV calculation, demonstrate why the same test result has different predictive value in high- vs. low-prevalence populations. Apply this to HIV ELISA in India — what are the national HIV prevalence figures that determine PPV in different population groups?
  • Discuss the biological reasons why a recent malaria infection (or other causes of polyclonal B-cell activation) can cause a false-positive HIV ELISA — what are the other common causes of false-positive HIV ELISA in Indian patients?

Competencies: MI1.11, MI1.4

Learning Issues

Research these questions and bring your findings to the discussion.

  1. [MI1.9] What are the specific components of pre-test informed consent before HIV ELISA, and what is the legal framework governing HIV testing in India (HIV and AIDS Prevention and Control Act, 2017)?
  2. [MI1.4] What is the confirmatory algorithm for HIV diagnosis in India — when is Western blot used, and what does an 'indeterminate' Western blot mean clinically?
  3. [MI1.8] What are the essential elements of post-test counselling for a reactive HIV ELISA, and how should this differ based on the test result (reactive, non-reactive, indeterminate)?
  4. [MI1.11] How does the concept of positive predictive value (PPV) explain why the same screening test result has different clinical significance in a low-prevalence versus a high-prevalence population?
  5. [MI1.5] What systems in the pre-analytical phase — from test requisition to specimen receipt in the laboratory — should be designed to protect patient confidentiality for high-sensitivity tests?
  6. [MI1.7] What professional obligations does laboratory staff (medical officer, technician, ward boy) have regarding patient information encountered in the course of specimen handling and result processing?